Skip to main content

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer

ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) — Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon Shoemaker as its new Chief Revenue Officer. In this role, Shoemaker will be responsible for overseeing the company’s revenue generation and growth strategies.

With an exceptional track record of leadership and a strong background in revenue growth and optimization, Shoemaker brings a wealth of experience to her new position. Her appointment marks a significant milestone for Psychemedics Corporation as it continues to expand its presence in the rapidly evolving field of substance abuse testing.

“We are thrilled to welcome Shannon Shoemaker to Psychemedics as our new Chief Revenue Officer,” said Brian Hullinger, CEO of Psychemedics Corporation. “Shannon’s impressive track record and dedication to excellence make her the ideal candidate to lead our strategic growth initiatives. We look forward to her contributions as we continue to innovate and grow in the industry.”

Shannon Shoemaker brings a wealth of experience to her role as the new Chief Revenue Officer at Psychemedics Corporation. Her career is marked by exceptional strategic leadership, consistently delivering outstanding results. Shoemaker’s ability to lead high-performing teams and develop successful growth strategies has led to the expansion of market presence, both domestically and internationally. Shoemaker’s career has been characterized by outstanding accomplishments and a dedication to excellence. She has received numerous accolades and awards throughout her professional career, including Business Women of the Year by CEO Today, The 10 Most Influential Businesswomen by CIO Look, and The 20 Most Successful Businesswomen to Watch by Insights Success.

For more information about Psychemedics Corporation and its innovative hair testing solutions, please visit https://www.psychemedics.com/.

About Psychemedics 

Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.

Investor Relations:
Phone: 978-206-8220
Email: InvestorRelations@psychemedics.com 

 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.